82 related articles for article (PubMed ID: 9530528)
1. Changes in the cardiovascular nitric oxide pathway in cyclosporin-A treated rats.
Rao MR; Hutcheson AE; Markov AK
Drug Chem Toxicol; 1998 Feb; 21(1):27-34. PubMed ID: 9530528
[TBL] [Abstract][Full Text] [Related]
2. Myocardial toxicity of cyclosporin A: inhibition of calcium ATPase and nitric oxide synthase activities and attenuation by fructose-1,6-diphosphate in vitro.
Hutcheson AE; Rao MR; Olinde KD; Markov AK
Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):17-26. PubMed ID: 7582858
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism.
Chander V; Tirkey N; Chopra K
Toxicology; 2005 May; 210(1):55-64. PubMed ID: 15804458
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclosporin A on the expression of inducible nitric oxide synthase in the gingiva of rats.
Gau CH; Chou TC; Chiu HC; Shen EC; Nieh S; Chiang CY; Fu E
J Periodontol; 2005 Dec; 76(12):2260-6. PubMed ID: 16332238
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Ferlito M; Deodato B; Arlotta M; Minutoli L; Campo GM; Bova A; Quartarone C; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat brain nitric oxide synthase activity by cyclosporin-A.
Rao MR; Kanji VK; Salahudeen MK; Wang C; Sekhar V
Indian J Exp Biol; 1996 Dec; 34(12):1265-7. PubMed ID: 9246923
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin inhibits nitric oxide production in medullary ascending limb cultured cells.
Wu MS; Yang CW; Bens M; Yu HM; Huang JY; Wu CH; Huang CC; Vandewalle A
Nephrol Dial Transplant; 1998 Nov; 13(11):2814-20. PubMed ID: 9829483
[TBL] [Abstract][Full Text] [Related]
8. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium.
Rezzani R; Rodella L; Dessy C; Daneau G; Bianchi R; Feron O
FEBS Lett; 2003 Sep; 552(2-3):125-9. PubMed ID: 14527673
[TBL] [Abstract][Full Text] [Related]
9. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of lipoic acid on oxidative and peroxidative damage in cyclosporine A-induced renal toxicity.
Amudha G; Josephine A; Sudhahar V; Varalakshmi P
Int Immunopharmacol; 2007 Nov; 7(11):1442-9. PubMed ID: 17761348
[TBL] [Abstract][Full Text] [Related]
11. Role of metoprolol, B1-adrenoceptor antagonist, thromboxane A2 and nitric oxide in CsA-induced hypertension.
Oriji GK
Prostaglandins Leukot Essent Fatty Acids; 2003 Mar; 68(3):233-8. PubMed ID: 12591008
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide in CsA-induced hypertension: role of beta-adrenoceptor antagonist and thromboxane A2.
Oriji GK; Schanz N
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):259-63. PubMed ID: 11993718
[TBL] [Abstract][Full Text] [Related]
13. Does methylene blue protect the kidney tissues from damage induced by ciclosporin A treatment?
Rezzani R; Rodella L; Corsetti G; Bianchi R
Nephron; 2001 Nov; 89(3):329-36. PubMed ID: 11598398
[TBL] [Abstract][Full Text] [Related]
14. Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
Bachetti T; Pasini E; Suzuki H; Ferrari R
Crit Care Med; 2003 May; 31(5):1509-14. PubMed ID: 12771626
[TBL] [Abstract][Full Text] [Related]
15. Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction.
Akiyama K; Suzuki H; Grant P; Bing RJ
J Mol Cell Cardiol; 1997 Jan; 29(1):1-9. PubMed ID: 9040016
[TBL] [Abstract][Full Text] [Related]
16. [Effect of cyclosporine A on myocardial calcineurin activity of the right ventricle and plasma NO, nitric oxide synthase and endothelin-1 levels in rats with chronic hypoxia].
Tan JX; Liu CZ; Jie YL; Wang Y; Huang YG
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):656-8. PubMed ID: 15201082
[TBL] [Abstract][Full Text] [Related]
17. Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity.
Yuan J; Zhou J; Chen BC; Zhang X; Zhou HM; Du DF; Chang S; Chen ZK
Transplant Proc; 2005 May; 37(4):1892-5. PubMed ID: 15919495
[TBL] [Abstract][Full Text] [Related]
18. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
20. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
Chander V; Chopra K
Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
